Location: Jacksonville (Headquarters)

3550 University Blvd South

Suite #101

Jacksonville, FL 32216

Tel: (904) 854-1354

Fax:

This phase 3 study is evaluating the efficacy and safety of study TQJ230 compared to placebo in the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a).

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Heart Disease

The purpose of this phase 2 study is to evaluate the bleeding profile of abelacimab compared to rivaroxaban in patients with atrial fibrillation (AF) at moderate-to-high risk of stroke.

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Atrial Fibrillation, Heart Disease

This is a randomized, double-blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of drug IONIS-AGT-LRx compared to placebo in patients with treatment-resistant hypertension (rHTN).

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Resistant Hypertension

This is a phase 2 study evaluating drug LY3437943 safety and effectiveness compared to placebo in subjects who are overweight or obese patients.

Location(s): Jacksonville (Headquarters)

Condition: Overweight/Obesity

This study compares insulin icodec (a new insulin taken once a week) to insulin glargine (an insulin taken once daily which is already available on the market) in people with type 2 diabetes.

Location(s): Jacksonville (Headquarters)

Condition: Diabetes

This is a randomized, double-blind, placebo-controlled, dose-ranging Phase 2 study to evaluate the efficacy and safety of drug CIN-107 compared to placebo in patients with treatment-resistant hypertension (rHTN). The study will assess three oral doses of CIN-107 versus placebo.

Location(s): Jacksonville (Headquarters)

Condition: Resistant Hypertension

This study is evaluating the InterStim Micro system performance and safety to confirm long term outcomes

Location(s): Jacksonville (Headquarters)

Condition: Fecal Incontinence, Non-obstructive Urinary Retention, Overactive Bladder

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine

Condition: Cholesterol, Heart Disease

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

Location(s): Jacksonville (Headquarters)

Condition: Diabetes